TD Asset Management’s Tvardi Therapeutics, Inc. Common Stock TVRD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q4 | – | Sell |
-539
| Closed | -$300K | – | 1556 |
|
|
2021
Q3 | $300K | Hold |
539
| – | – | ﹤0.01% | 1452 |
|
|
2021
Q2 | $232K | Hold |
539
| – | – | ﹤0.01% | 1471 |
|
|
2021
Q1 | $421K | Hold |
539
| – | – | ﹤0.01% | 1421 |
|
|
2020
Q4 | $294K | Hold |
539
| – | – | ﹤0.01% | 1387 |
|
|
2020
Q3 | $247K | Hold |
539
| – | – | ﹤0.01% | 1323 |
|
|
2020
Q2 | $332K | Hold |
539
| – | – | ﹤0.01% | 1259 |
|
|
2020
Q1 | $256K | Hold |
539
| – | – | ﹤0.01% | 1290 |
|
|
2019
Q4 | $313K | Hold |
539
| – | – | ﹤0.01% | 1312 |
|
|
2019
Q3 | $355K | Hold |
539
| – | – | ﹤0.01% | 1230 |
|
|
2019
Q2 | $417K | Hold |
539
| – | – | ﹤0.01% | 1212 |
|
|
2019
Q1 | $381K | Hold |
539
| – | – | ﹤0.01% | 1232 |
|
|
2018
Q4 | $252K | Hold |
539
| – | – | ﹤0.01% | 1331 |
|
|
2018
Q3 | $465K | Hold |
539
| – | – | ﹤0.01% | 1302 |
|
|
2018
Q2 | $372K | Buy |
539
+6
| +1% | +$4.14K | ﹤0.01% | 1325 |
|
|
2018
Q1 | $238K | Hold |
533
| – | – | ﹤0.01% | 1302 |
|
|
2017
Q4 | $235K | Sell |
533
-11
| -2% | -$4.85K | ﹤0.01% | 1286 |
|
|
2017
Q3 | $268K | Buy |
544
+133
| +32% | +$65.5K | ﹤0.01% | 1252 |
|
|
2017
Q2 | $228K | Buy |
+411
| New | +$228K | ﹤0.01% | 1297 |
|